Negative Pressure Wound Therapy Pump Extricare 2400, Model EC2400-E, Registration 80047309100, Lot 41513 // Extricare 2400 Bandages, Models EC2400-LO-E; EC2400-SO-E; EC2400-SE; EC2400-HE; EC2400-MN-E; EC2400-IM-E; EC2400-FE, Registration 80047300462, lot 41523 의 안전성 경고

Agência Nacional de Vigilância Sanitária (ANVISA)에 따르면, 해당 안전성 경고 는 Brazil 에서 MEDSTAR IMPORTAÇÃO E EXPORTAÇÃO LTDA.; Devon Medical Products 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

안전성 경고는 의료기기 제품과 관련된 중요한 정보와 권고사항을 담고 있습니다. 물론 안전성 경고가 배포되었다고 해서 해당 제품이 무조건 안전하지 않은 제품이라는 것은 아닙니다. 보건의료업계 종사자와 의료기기 사용자들에게 배포되는 안전성 경고에는 회수(recall)도 포함될 수 있습니다. 제조사가 안전성 경고를 작성하기도 하지만, 보건당국에서 작성하는 경우도 있습니다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Safety alert
  • 사례 ID
    1570
  • 날짜
    2015-04-28
  • 사례 국가
  • 사례 출처
    ANVISA
  • 사례 출처 URL
  • 비고 / 경고
    Brazilian data is current through June 2018. All of the data comes from Anvisa, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Brazil.
  • 데이터 추가 비고
    The various modes of failure of the ExtriCare and the complaints were presented to a panel of three independent external medical specialists (March 19, 2015, Herlev University Hospital, Copenhagen, Denmark) for the purpose of obtaining an external assessment of the related safety concerns with the use of ExtriCare. The experts confirmed the link between failure modes and risk for patients, based on their clinical experience and the literature. The malfunction of the ExtriCare NPWT system poses serious risks to patient safety in terms of localized infections, systemic infections (sepsis), and delayed wound healing.
  • 원인
    The company responsible for product marketing received some notifications related to product problems, as follows: vacuum lack or instability from the pump, stagnation of the wound exudate in the tubing while the npwt system is in operation, and reflux of the exudate of the wound from the tubing and reservoir to the wound while the npwt system is in operation. / 2) leakage of the pipe from the suction port. / 3) leakage of air from the suction port. / 4) leaking air from the suction port and detaching the tubing from the suction port.
  • 조치
    The company advises customers to perform the inventory review and separation of the affected products for recall. Further information: sac@medstar.com.br